FLDM News Alert Fluidigm Corp (FLDM) 37.93 02/14/2015 19:51:

New Post Public Reply Private Reply Replies (0) Message Board

Feb 14, 2015 at 8:51 PM

Fluidigm Corp (FLDM) 37.93 $FLDM

Earnings Estimates Moving Higher for Fluidigm (FLDM): Time to Buy? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 7:59AM CST
Fluidigm has decent short-term momentum and it is seeing solid activity on the earnings estimate revision front as well
FLDM: 37.93 (-0.47)

Fluidigm Q4 Loss Narrower Than Expected, Revenues Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 8:10AM CST
Following the earnings announcement on Feb 5, shares of Fluidigm Corp (FLDM) rallied nearly 2.8% to open at $39.85 on Friday.
ABMD: 60.39 (+0.46), FLDM: 37.93 (-0.47), INGN: 33.53 (+2.32), LMNX: 15.45 (+0.02)

Fluidigm's (FLDM) CEO Gajus Worthington on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 05, 7:11PM CST

FLDM: 37.93 (-0.47)

Fluidigm reports 4Q loss
Automated Insights - Thu Feb 05, 4:39PM CST
SOUTH SAN FRANCISCO, Calif. (AP) _ Fluidigm Corp. (FLDM) on Thursday reported a loss of $10.9 million in its fourth quarter.
FLDM: 37.93 (-0.47)

Fluidigm (FLDM) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Feb 05, 3:55PM CST

FLDM: 37.93 (-0.47)

Fluidigm beats by $0.46, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 3:32PM CST

FLDM: 37.93 (-0.47)

Science for Life Laboratory Forms Swedish National Center for Single-Cell Biology
Business Wire - Thu Feb 05, 3:05PM CST
Fluidigm Corporation (NASDAQ:FLDM) today announced that Science for Life Laboratory (SciLifeLab) has established the Swedish National Center for Single-Cell Biology. The center features six C1(TM) systems, three CyTOF(R) 2 systems and a Biomark(TM) HD system, making SciLifeLab one of the preeminent users of the full line of Fluidigm's single-cell technologies in the world.
FLDM: 37.93 (-0.47)

Fluidigm Reports Q4 and Full Year 2014 Financial Results
Business Wire - Thu Feb 05, 3:00PM CST
Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the fourth quarter and full year ended December 31, 2014.
FLDM: 37.93 (-0.47)

Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 4:35PM CST

BEBE: 3.90 (+0.01), ACET: 20.00 (+0.27), ARCW: 6.62 (+0.23), CPST: 0.73 (+0.03), AIV: 38.55 (-0.50), DV: 36.69 (+0.04), EGAN: 3.78 (+0.08), CUTR: 11.94 (-0.21), MTD: 307.00 (-0.13), PXLW: 5.24 (-0.22), LNKD: 269.00 (+1.83), ADNC: 4.59 (-0.02), LGF: 32.17 (+0.08), AHL: 46.44 (-0.29), HME: 67.76 (-0.96), PDFS: 18.31 (+0.04), MCK: 224.89 (+0.12), KRG: 29.17 (+0.23), ATHN: 134.60 (+4.95), PCTY: 28.59 (+0.38), BRS: 61.71 (+3.65), ECOM: 9.69 (+0.63), FWM: 5.55 (+0.08), EXPE: 89.49 (-0.08), NTGR: 31.63 (+0.23), IMPV: 43.17 (+1.38), OLN: 27.31 (+0.13), MRIN: 7.04 (+0.04), BWLD: 187.27 (+0.30), ASYS: 9.87 (+0.30), DCT: 36.70 (+0.23), BCOV: 8.43 (+0.27), MXWL: 6.47 (+0.07), CME: 93.92 (-1.39), ATVI: 23.11 (+0.17), KIM: 26.83 (-0.25), P: 15.44 (+0.45), BMI: 60.09 (+0.56), OUTR: 68.39 (+2.22), CTRL: 13.39 (+0.10), GPRO: 45.27 (-0.02), ECHO: 26.72 (+0.35), RDEN: 16.59 (+0.90), NUAN: 14.26 (+0.20), ATR: 64.56 (+0.49), ACLS: 2.81 (+0.04), EGOV: 16.20 (+0.30), PDM: 18.79 (-0.15), FLDM: 37.93 (-0.47), BRKS: 12.08 (+0.04), FLT: 150.37 (+1.15), ASEI: 56.82 (+0.30), ENH: 64.63 (+0.15), CALD: 14.95 (+0.03), ONNN: 11.94 (+0.33), LF: 2.51 (+0.06)

Will Fluidigm (FLDM) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 30, 8:15AM CST
Will Fluidigm (FLDM) Continue to Surge Higher?
FLDM: 37.93 (-0.47)

Fluidigm reports February 5
Seeking Alpha - at Seeking Alpha - Tue Jan 27, 8:20AM CST

FLDM: 37.93 (-0.47)

Fluidigm to Announce Q4/Full Year 2014 Financial Results and Host Conference Call for Investors
Business Wire - Tue Jan 27, 8:02AM CST
Fluidigm Corporation (NASDAQ:FLDM) will report its fourth quarter and 2014 full year financial results on February 5, 2015, after close of market.
FLDM: 37.93 (-0.47)

Nasdaq stocks posting largest percentage increases
AP - Wed Jan 21, 12:22PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
NFLX: 466.10 (+9.37), ASPS: 22.32 (+0.09), FLDM: 37.93 (-0.47), MCEP: 6.29 (+0.12), MSON: 12.47 (-0.40), SCYX: 9.48 (+0.07), ADHD: 6.92 (+0.73), GWGH: 6.64 (unch), FANG: 73.46 (+0.49), PDCE: 49.17 (+0.60)

Strength Seen in Fluidigm (FLDM): Stock Moves 9.8% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 21, 8:25AM CST
Fluidigm (FLDM) was a big mover last session, with shares rising nearly 10% on the day.
FLDM: 37.93 (-0.47), INGN: 33.53 (+2.32)

Fluidigm's Preliminary Q4 Revenues Up Y/Y, Outlook Positive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 14, 4:30PM CST
Fluidigm Corp (FLDM) recently announced its preliminary fourth-quarter 2014 revenues.
TMO: 127.61 (+0.78), FLDM: 37.93 (-0.47), ILMN: 198.54 (+1.81), AFFX: 11.45 (+0.02)

Fluidigm reports preliminary results and provides outlook for 2015
Seeking Alpha - at Seeking Alpha - Tue Jan 13, 3:12PM CST

FLDM: 37.93 (-0.47)

Fluidigm Announces Preliminary Fourth Quarter 2014 Revenue and Issues 2015 Revenue Guidance
Business Wire - Tue Jan 13, 3:00PM CST
Fluidigm Corporation (NASDAQ:FLDM) today announced total revenue for the fourth quarter of 2014 is expected to be approximately $33.4 million based on preliminary, unaudited financial data. Organic revenue for the fourth quarter of 2014 (excluding revenue attributable to the DVS Sciences acquisition, comprised of the CyTOF(R) 2 system and proteomics analytical consumables) is expected to be approximately $25.2 million.
FLDM: 37.93 (-0.47)

Fluidigm to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Business Wire - Mon Jan 05, 8:01AM CST
Fluidigm Corporation (NASDAQ:FLDM) today announced that Chief Executive Officer and President Gajus Worthington will present at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco, on Thursday, January 15, 2015 at 8:30 a.m. (PT).
JPM: 59.67 (+0.10), FLDM: 37.93 (-0.47)

Walgreens Investors' Final Nod for Alliance Boots Takeover - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 30, 3:40PM CST
Walgreens' (WAG) partnership with Alliance Boots has been yielding positive results, with combined synergies reaching $140 million in first-quarter fiscal 2015.
ETRM: 1.21 (+0.06), FLDM: 37.93 (-0.47), INGN: 33.53 (+2.32), WAG: 76.05 (-0.49)

RTI Surgical Now a Strong Buy, Raised Guidance a Positive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 30, 3:20PM CST
On Dec 30, 2014, Zacks Investment Research upgraded RTI Surgical Inc. (RTIX) to a Zacks Rank #1 (Strong Buy).
ETRM: 1.21 (+0.06), RTIX: 5.54 (+0.19), FLDM: 37.93 (-0.47), INGN: 33.53 (+2.32)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Laars Welcomes Women in Manufacturing to Facility Tour

Opening Doors and Minds in Manufacturing On October 15, Laars Heating Systems throws wide open its Rochester, N.H., facility to a group that's rewriting the rulebook: women in manufacturing. It's not just another day in the life of assembly lines and engineering desks, folks. This is about giving a platform to those often sidelined in the field of boilers and water...

Think Tank Pushes for Bold Parkinson's Prevention Plan

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Simple Home Upgrades That Boost Value Fast

Transform Your Home's Curb Appeal Without Breaking The Bank Every homeowner knows that feeling when you look at your house one day and think, "This could use a little something." Say you're strolling through a neighborhood in Fulton, N.Y., and notice a gem. It's not a brand new build, but it gleams with character. You bet it's had a few smart touches that could apply...

New Data on SKYRIZI Offers Hope for Crohn's Patients

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Home Buying: Unmasking All the Real Budget Costs

Home Buying: More Costs Than Meets the Eye Let's face it, buying a home is no stroll in the park. It's a tangled web of numbers and surprises that can leave even the savviest buyer in a daze. Thank goodness for articles like the one from HelloNation featuring Serena LoPiccolo-Smith, which make the invisible visible when it comes to the financial intricacies of home...

TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

Canada and Ukraine Fortify Defense with UGV Partnership

New Defense Fronts: Canada and Ukraine Join Forces October 13, 2026, marks an important day in Ottawa's defense narrative with Dominion Dynamics and Ukraine's TENCORE kicking off a robust partnership. They're not just collaborating; they're plugging into each other's strengths to build TerMIT uncrewed ground vehicles (UGVs) on Canadian soil. These aren't gizmos you find...

Dr. Anderson’s Journey: Leadership with Faith and Service

A Life Shaped by Service Dr. Howard Anderson isn't just another name in a glossy award roster—he's a powerhouse of leadership, a chaplain of compassion, and a soldier in spirit. Honored as a Pinnacle Professional Member of The Inner Circle of Excellence, his recognition feels less like an accolade and more like a testament to a life committed to serving others. The...

Partner Valuation Advisors Bolsters Team with Eichman

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Montesodi 2023: A Fresh Chapter in Chianti Excellence

A Glass Filled with History and Nature's Whimsy When you pour a glass of Montesodi 2023, you’re not just tasting wine but a story—a saga that blends Tuscany’s rich vineyard history with last year's unpredictable weather. Marchesi Frescobaldi, a name that’s seen it all over its thousand years, has once again shown us how resilience and tradition can marry with...